SHOOT MERISTEM SPECIFIC PROMOTER SEQUENCES

Abstract: A novel tissue-specific promoter is provided which has been isolated from the upstream non-coding region of a plant UFO gene. This promoter, operably associated with a nucleic acid sequence expressing a product of interest, initiates and regulates the transcription of such sequences in a shoot meristem-specific tissue.

Description: SHOOT MERISTEM SPECIFIC PROMOTER SEQUENCES Statement as to Federally Sponsored Research This invention was made with Government support under Grant No. IBN- 9406948 awarded by the National Science Foundation. The Government has certain rights in this invention. Field of the Invention This invention relates generally to plant genetic engineering, and specifically to a tissue specific promoter capable of directing shoot meristem-specific expression. Background of the Invention Genes are regulated in an inducible, tissue specific or constitutive manner. There are different types of structural elements which are involved in the regulation of gene expression. Cis-acting elements, located in the proximity of, or within genes, serve to bind sequence-specific DNA binding proteins, i.e., trans-acting factors. The binding of proteins to DNA is responsible for the initiation, maintenance, or down- regulation of gene transcription. Cis-acting elements which control genes include promoters, enhancers and silencers. Promoters are positioned next to the transcription start site and function in an orientation-dependent manner, while enhancer and silencer elements, which modulate the activity of promoters, may be flexible with respect to their orientation and distance from the transcription start site. Various promoter sequences are available which may be used in the genetic engineering of plants. Such promoters may be utilized to initiate transcription of a nucleic acid sequence of interest operably linked at the 3' end of the promoter region. Promoters often have transcription specific characteristics such as strength, tissue specificity, developmental stage specificity, etc. Gene expression in plants may be driven by a number of promoters. Although the endogenous promoter of a gene of interest may be utilized for transcriptional regulation of the gene, the promoter may also be a foreign regulatory sequence. Examples of viral promoters utilized in plant expression vectors include the 35S RNA and 19S RNA promoters of CaMV (Brisson, et al.. Nature, 3_LO:51 1 , 1984; Odell, et al., Nature, 313:810. 1985); the full-length transcript promoter from Figwort Mosaic Virs (FMV) (Gowda, et al., J. Cell Biochem. , 13D: 301 , 1989) and the coat protein promoter of TMV (Takamatsu. et al., EMBO J. 6:307, 1987). Plant promoters also include the light-inducible promoter from the small subunit of ribulose bis- phosphate carboxylase (ssRUBISCO) (Coruzzi. et al.. EMBO J. , 3 : 1671 , 1984; Broglie, et al., Science, 224:838, 1984); mannopine synthase promoter (Velten. et al., EMBO J, 3:2723, 1984) nopaline synthase (NOS) and octopine synthase (OCS) promoters (carried on tumor-inducing plasmids of Agrobacterium tumefaciens) and heat shock promoters, e.g., soybean hspl7.5-E or hspl 7.3-B (Gurley. et al., Mol. Cell. Biol , 6:559, 1986; Severin, et al., Plant Mol. Biol, 15:827, 1990). Promoters utilized in plant genetic engineering include both constitutive and inducible natural promoters as well as engineered promoters. The CaMV promoters are examples of constitutive promoters. To be useful, an inducible promoter should 1) provide low expression in the absence of the inducer; 2) provide high expression in the presence of the inducer; 3) use an induction scheme that does not interfere with the normal physiology of the plant; and 4) have no effect on the expression of other genes. Ex.amples of inducible promoters useful in plants include those induced by chemical means, such as the yeast metallothionein promoter which is activated by copper ions (Mett, et al, Proc. Natl. Acad. Sci., U.S.A., 90:4567, 1993); In2-1 .and In2-2 regulator sequences which are activated by substituted benzenesulfonamides, e.g., herbicide safeners (Hershey, et al., Plant Mol. Biol , 17:679, 1991); and the GRE regulatory sequences which are induced by glucocorticoids (Schena, et al., Proc. Natl. Acad. Sci., U.S.A., S : 10421 , 1991). Tissue specific promoters may also be utilized for expression of genes in plants. Tissue specific promoters useful in transgenic plants include the cdc2a promoter and cyc07 promoter (Ito, et al., Plant Mol. Biol., 24:863, 1994; Martinez, et al., Proc. Natl. Acad. Sci. USA, 89:7360, 1992; Medford, et al., Plant Cell, 3:359, 1991 ; Terada, et al. , Plant Journal, 3:241 , 1993; Wissenbach, et a!., Plant Journal, 4:41 1, 1993). Additional tissue specific promoters that are utilized in plants include the histone promoter (Atanassova, et al., Plant Journal, 2:291 , 1992); the cinnamyl alcohol dehydrogenase (CAD) promoter (Feuillet, et al.. Plant Mol. Biol.. 27:651 , 1995); the mustard CHS1 promoter (Kaiser, et al.. Plant Mol. Biol., 28:231, 1995); the bean grp 1.8 promoter (Keller, et al., Plant Mol. Biol., 26:747, 1994): the PALI promoter (Ohl, et al., Plant Cell, 2:837, 1990); and the chalcone synthase A promoter (Plant Mol. Biol., 15:95-109, 1990). Summary of the nvention The present invention provides a novel tissue-specific promoter isolated from the Unusual Floral Organ gene (UFO). Transgenic plants, in which the invention promoter is fused to a nucleic acid sequence expressing a product of interest, exhibit phenotypes that indicate that the promoter can drive functional expression of a heterologous gene in shoot meristems. In a first embodiment, the invention provides a nucleic acid construct comprising a non-coding regulatory sequence isolated from a plant Unusual Floral Organs (UFO) gene and a nucleic acid sequence, wherein said nucleic acid sequence expresses a product selected from a protein of interest or antisense RNA. and wherein said nucleic acid sequence is heterologous to the non-coding sequence. The construct is useful for the production of transgenic plants which express a gene of interest in a shoot meristem-specific manner. In a second embodiment, the invention provides transgenic plant cells comprising the nucleic acid constructs of the invention as well as plants comprising such cells. In a further embodiment, the invention provides a method of providing increased transcription of a nucleic acid sequence expressing a product selected from a protein of interest or antisense RNA. The method comprises providing a plant having integrated in its genome a nucleic acid construct of the invention and subjecting the plant to conditions suitable for growth. Brief Description of the Drawings Figure 1 A is the nucleotide and deduced amino acid sequence of the UFO gene and some 5' and 3' noncoding sequences. Figure I B is the nucleotide sequence of the 3'-terminal 2.6 kb of the UFO promoter. The initiation codon, ATG, is underlined. Figure 2 is a comparison of UFO and FIM protein sequences and location of ufo mutations associated with alleles ιιfo-2 through ufo-6. Figure 3 is a restriction map of the UFO promoter. Figure 4 shows photographs of GUS activity in UFO::GUS transgenic plants during early heart stage (panel A), the torpedo stage (panel B), young seedlings (panel C), and after floral induction (panel D). Description of the Preferred Embodiments The present invention provides a novel promoter sequence that is useful for shoot meristem-specific gene expression. The shoot apical meristem forms the primary plant body and often undergoes differentiation to form a flower. In accordance with the present invention, a nucleic acid construct is provided which allows for modification of a plant phenotype based on expression of a desired gene in the shoot meristem. The nucleic acid construct comprises a sequence of interest which provides for the modification in phenotype, positioned downstream from and under the transcriptional initiation regulation of the invention shoot-specific promoter. The shoot meristem-specific promoter is useful for specific expression, in the shoot meristem, of genes involved in regulating development. Such genes include those involved in flowering, as well as genes that protect against pathogens by encoding toxins. In a first embodiment, the invention provides a nucleic acid construct comprising a non-coding regulatory sequence isolated upstream from a plant Unmual Floral Organs (UFO) gene, wherein the non-coding regulatory sequence is operably associated with a nucleic acid sequence expressing a product selected from a protein of interest or antisense RNA and wherein said nucleic acid sequence is heterologous to said non-coding sequence. The construct includes a transcriptional and translational initiation region and a transcriptional and translational termination region functional in plants. In preparing the construct, the various component nucleic acid sequences may be manipulated, so as to provide for nucleic acid sequences in the proper orientation and in the proper reading frame. The UFO gene regulatory sequence, or promoter, is located in the non- coding region of the gene and exhibits strong expression in the shoot apical meristem. Approximately 4 kilobases of 5' non-coding sequence was isolated upstream from the coding sequence, as described in the Examples described herein. Figure 1 B shows the sequence of approximately 2.6 kb of the 3'-terminal region of the promoter. The main transcription start site is at -225bp relative to the ATG initiation codon which is underlined. The transcription initiation sequences include transcriptional control regions such as TATAA and CAAT box sequences as well as sequences which regulate the tissue specificity of the transcribed product. In the nucleic acid construct of the invention, the ATG start codon is typically provided by the nucleic acid sequence expressing the product of interest. One may identify a convenient restriction site in the 5 '-untranslated region of the UFO gene and in the 5' region of the nucleic acid sequence expressing the product of interest and employ an adapter which will join the two sequences. Alternatively, one may introduce a polylinker immediately downstream from the UFO noncoding region for insertion of the nucleic acid sequence expressing the product of interest. Placing a nucleic acid sequence expressing a product of interest under the regulatory control of a promoter or a regulatory element means positioning the sequence such that expression is controlled by the promoter or regulatory element. In general, promoters are positioned upstream of the genes that they control. Thus, in the construction of promoter/gene combinations, the promoter is preferably positioned upstream of the gene and at a distance from the transcription start site that approximates the distance between the promoter and the gene it controls in its natural setting. As is known in the art, some variation in this distance can be tolerated without loss of promoter function. Similarly, the preferred positioning of a regulatory element with respect to a gene placed under its control reflects its natural position relative to the structural gene it naturally regulates. Again, as is known in the art, some variation in this distance can be accommodated. The 5'-noncoding sequences which are used in the invention construct are not more than about 4 kbp in length. Promoter function during expression of a gene under its regulatory control can be tested at the transcriptional stage using DNA/R A and RNA/RNA hybridization assays (in situ hybridization) and at the translational stage using specific functional assays for the protein synthesized (for example, by enzymatic activity or by immunoassay of the protein). As used herein, the term "nucleic acid sequence" refers to a polymer of deoxyribonucleotides or ribonucleotides, in the form of a separate fragment or as a component of a larger construct. Nucleic acids expressing the products of interest can be assembled from cDNA fragments or from oligonucleotides which provide a synthetic gene which is capable of being expressed in a recombinant transcriptional unit. Polynucleotide or nucleic acid sequences of the invention include DNA, RNA and cDNA sequences. Nucleic acid sequences utilized in the invention can be obtained by several methods. For example, the DNA can be isolated using hybridization procedures which are well known in the art. These include, but are not limited to: 1 ) hybridization of probes to genomic or cDNA libraries to detect shared nucleotide sequences; 2) antibody screening of expression libraries to detect shared structural features and 3) synthesis by the polymerase chain reaction (PCR). Sequences for specific genes can also be found in GenBank, National Institutes of Health computer database. The phrase "nucleic acid sequence expressing a product of interest" refers to a structural gene which expresses a product selected from a protein of interest or antisense RNA. The term "structural gene" excludes the non-coding regulatory sequence which drives transcription. The structural gene may be derived in whole or in part from any source known to the art, including a plant, a fungus, an animal, a bacterial genome or episome, eukaryotic, nuclear or plasmid DNA, cDNA, viral DNA or chemically synthesized DNA. A structural gene may contain one or more modifications in either the coding or the untranslated regions which could affect the biological activity or the chemical structure of the expression product, the rate of expression or the manner of expression control. Such modifications include, but are not limited to, mutations, insertions, deletions and substitutions of one or more nucleotides. The structural gene may constitute an uninterrupted coding sequence or it may include one or more introns, bound by the appropriate splice junctions. The structural gene may also encode a fusion protein. It is contemplated that introduction into plant tissue of nucleic acid constructs of the invention will include constructions wherein the structural gene and its promoter e.g., UFO promoter, are each derived from different plant species. The term "heterologous nucleic acid sequence" as used herein refers to at least one structural gene which is operably associated with the regulatory sequence or promoter of the invention. The nucleic acid sequence originates in a foreign species, or, in the same species if substantially modified from its original form. For example, the term "heterologous nucleic acid sequence" includes a nucleic acid originating in the same species, where such sequence is operably linked to a promoter that differs from the natural or wild-type promoter (e.g., UFO promoter). The term "operably associated" refers to functional linkage between the promoter sequence and the structural gene regulated by the promoter sequence. The operably linked promoter controls the expression of the product expressed by the structural gene. Examples of structural genes that may be employed in the present invention include the Bacillus thuringiensis toxin gene, which provides pest/pathogen protection and the LEAFY gene, which controls flowering in plants. A variety of structural genes of interest that can be operably linked to the promoter of the invention are available. For example, various sequences may be employed relating to enhanced resistance to pesticides. Such sequences provide for the expression of a protein toxin derived from, for example, Bacillus thuringiensis. Moreover, sequences relating to herbicides may also be employed. Such sequences can provide for the expression of a mutated 5-enolpyruvyl-2-phosphoshikimate synthase to provide decreased sensitivity to glyphosate. Such sequences can also provide for the expression of a gene product involved in detoxification of bromoxynil. Sequences may also be employed relating to enhanced resistance to stress (such as provided by a gene for superoxide dismutase), temperature changes, osmotic pressure changes and salinity (such as a gene associated with the oveφroduction of proline) and the like. Growth of the shoot meristem may be modulated, either increased or decreased, depending on the particular need. Antisense sequences may be used to reduce growth or other phenotypic traits. The term "genetic modification" or "genetically modified" as used herein refers to the introduction of one or more heterologous nucleic acid sequences into one or more plant cells, which can generate whole, sexually competent, viable plants. The term "genetically modified" as used herein refers to a plant which has been generated through the aforementioned process. Genetically modified plants of the invention are capable of self-pollinating or cross-pollinating with other plants of the same species so that the foreign gene, carried in the germ line, can be inserted into or bred into agriculturally useful plant varieties. The term "plant cell" as used herein refers to protoplasts, gamete producing cells, and cells which regenerate into whole plants. Plant cells include cells in plants as well as protoplasts in culture. Accordingly, a seed comprising multiple plant cells capable of regenerating into a whole plant, is included in the definition of "plant cell". Plant tissue includes differentiated and undifferentiated tissue derived from roots, shoots, pollen, seeds, tumor tissue, such as crown galls, and various forms of aggregations of plant cells in culture, such as embryos and calluses. As used herein, the term "plant" refers to either a whole plant, a plant part, a plant cell, or a group of plant cells, such as plant tissue, for example. Plantlets are also included within the meaning of "plant". Plants included in the invention are any plants amenable to transformation techniques, including angiosperms, gymnosperms, monocotyledons and dicotyledons. Examples of monocotyledonous plants include, but are not limited to, asparagus, field and sweet corn, barley, wheat, rice, sorghum, onion, pearl millet, rye and oats. Examples of dicotyledonous plants include, but are not limited to tomato, tobacco, cotton, rapeseed, field beans, soybeans, peppers, lettuce, peas, alfalfa, clover, cole crops or Brassica oleracea (e.g., cabbage, broccoli, cauliflower, brussel sprouts), radish, carrot, beats, eggplant, spinach, cucumber, squash, melons, cantaloupe, sunflowers and various ornamentals. Woody species include poplar, pine, sequoia, cedar, oak. etc. Genetically modified plants of the present invention are produced by contacting a plant cell with an invention nucleic acid construct as described above. The construct is preferably contained within a vector. Vector(s) employed in the present invention for transformation of a plant cell for shoot meristem expression comprise a nucleic acid sequence comprising at least one structural gene expressing a product of interest, operably associated with the promoter of the invention. It is preferred that the vector harboring the heterologous nucleic acid sequence also contain one or more selectable marker genes so that the transformed cells can be selected from non-transformed cells in culture, as described herein. As used herein, the term "marker" refers to a gene encoding a trait or a phenotype which permits the selection of, or the screening for. a plant or plant cell containing the marker. Preferable, the marker gene is an antibiotic resistance gene whereby the appropriate antibiotic can be used to select for transformed cells from among cells that are not transformed. Examples of suitable selectable markers include adenosine deaminase, dihydrofolate reductase, hygromycin-beta-phosphotransferase, thymidine kinase, exanthineguanine phospho-ribosyltransferase and amino-glycoside 3'-O-phosphotransferase II. Other suitable markers will be known to those of skill in the art. To commence a transformation process in accordance with the present invention, it is first necessary to construct a suitable vector and properly introduce it into the plant cell. The details of the construction of the vectors then utilized herein are known to those skilled in the art of plant genetic engineering. For example, the nucleic acid sequences utilized in the present invention can be introduced into plant cells using Ti plasmids, root-inducing (Ri) plasmids, and plant virus vectors. (For reviews of such techniques see, for example, Weissbach & Weissbach, 1988, Methods for Plant Molecular Biology, Academic Press. NY, Section VIII, pp. 421-463; and Grierson & Corey, 1988, Plant Molecular Biology, 2d Ed., Blackie, London, Ch. 7-9, and Horsch, et al, Science, 227: 1229, 1985, both incorporated herein by reference). One of skill in the art will be able to select an appropriate vector for introducing the invention nucleic acid construct in a relatively intact state. Thus, any vector which will produce a plant carrying the introduced nucleic acid construct should be sufficient. Even a naked piece of nucleic acid would be expected to be able to confer the properties of this invention, though at low efficiency. The selection of the vector, or whether to use a vector, is typically guided by the method of transformation selected. The transformation of plants in accordance with the invention may be carried out in essentially any of the various ways known to those skilled in the art of plant molecular biology. (See, for example, Methods of Enzymology, Vol. 153, 1987, Wu and Grossman, Eds., Academic Press, incoφorated herein by reference). As used herein, the term "transformation" means alteration of the genotype of a host plant by the introduction of a nucleic acid construct as described herein. For example, a construct of the invention can be introduced into a plant cell utilizing Agrobacterium tumefaciens containing the Ti plasmid. In using an A. tumefaciens culture as a transformation vehicle, it is most advantageous to use a non- oncogenic strain of the Agrobacterium as the vector carrier so that normal non- oncogenic differentiation of the transformed tissues is possible. It is also preferred that the Agrobacterium harbor a binary Ti plasmid system. Such a binary system comprises 1) a first Ti plasmid having a virulence region essential for the introduction of transfer DNA (T-DNA) into plants, and 2) a chimeric plasmid. The chimeric plasmid contains at least one border region of the T-DNA region of a wild- type Ti plasmid flanking the nucleic acid to be transferred. Binary Ti plasmid systems have been shown effective to transform plant cells (De Framond. Biotechnology, 1:262, 1983; Hoekema, et al, Nature, 303: 179, 1983). Such a binary system is preferred because it does not require integration into Ti plasmid in Agrobacterium. Methods involving the use of Agrobacterium include, but are not limited to: 1 ) co-cultivation of Agrobacterium with cultured isolated protoplasts: 2) transformation of plant cells or tissues with Agrobacterium; or 3) transformation of seeds, apices or meristems with Agrobacterium. In addition, gene transfer can be accomplished by in situ transformation by Agrobacterium, as described by Bechtold, et al, (CR. Acad. Sci. Paris, 316: 1 194, 1993) and exemplified in the Examples herein. This approach is based on the vacuum infiltration of a suspension of Agrobacterium cells. The preferred method of introducing a nucleic acid construct of the invention into plant cells is to infect such plant cells, an explant, a meristem or a seed, with transformed Agrobacterium tumefaciens as described above. Under appropriate conditions known in the art, the transformed plant cells are grown to form shoots, roots, .and develop further into plants. Alternatively, a nucleic acid construct of the invention can be introduced into a plant cell by contacting the plant cell using mechanical or chemical means. For example, the nucleic acid can be mechanically transferred by microinjection directly into plant cells by use of micropipettes. Alternatively, the nucleic acid may be transferred into the plant cell by using polyethylene glycol which forms a precipitation complex with genetic material that is taken up by the cell. A nucleic acid construct of the invention can also be introduced into plant cells by electroporation (Fromm, et al, Proc. Natl. Acad. Sci., U.S.A., 82:5824, 1985, which is incoφorated herein by reference). In this technique, plant protoplasts are electroporated in the presence of vectors or nucleic acids containing the relevant nucleic acid sequences. Electrical impulses of high field strength reversibly permeabilize membranes allowing the introduction of nucleic acids. Electroporated plant protoplasts reform the cell wall, divide and form a plant callus. Selection of the transformed plant cells with the transformed gene can be accomplished using phenotypic markers as described herein. Another method for introducing nucleic acid into a plant cell is high velocity ballistic penetration by small particles with the nucleic acid to be introduced contained either within the matrix of small beads or particles, or on the surface thereof (Klein, et al, Nature 327:70, 1987). Although, typically only a single introduction of a new nucleic acid sequence is required, this method particularly provides for multiple introductions. Cauliflower mosaic virus (CaMV) may also be used as a vector for introducing a nucleic acid construct of the invention into plant cells (US Patent No. 4,407,956). CaMV viral DNA genome is inserted into a parent bacterial plasmid creating a recombinant DNA molecule which can be propagated in bacteria. After cloning, the recombinant plasmid again may be cloned and further modified by introduction of the desired nucleic acid sequence. The modified viral portion of the recombinant plasmid is then excised from the parent bacterial plasmid, and used to inoculate the plant cells or plants. In another embodiment, the invention affords a method of providing increased transcription of a nucleic acid sequence expressing a product of interest in shoot meristem tissue. The method comprises providing a plant having integrated into its genome a nucleic acid construct of the invention and subjecting the plant to conditions suitable for growth whereby transcription of the nucleic acid sequence is increased in the shoot meristem tissue.. Typically, the nucleic acid construct is introduced into a plant cell by contacting the cell with a vector containing the promoter-nucleic acid sequence encoding the protein of interest construct. As used herein, the term "contacting" refers to any means of introducing the vector(s) into the plant cell, including chemical and physical means as described above. Preferably, contacting refers to introducing the nucleic acid or vector into plant cells ( including an explant. a meristem or a seed), via Agrobacterium tumefaciens transformed with the heterologous nucleic acid as described above. Normally, a plant cell is regenerated to obtain a whole plant from the transformation process. The immediate product of the transformation is referred to as a "transgenote". The term "growing" or "regeneration" as used herein means growing a whole plant from a plant cell, a group of plant cells, a plant part (including seeds), or a plant piece (e.g., from a protoplast, callus, or tissue part). Regeneration from protoplasts varies from species to species of plants, but generally a suspension of protoplasts is first made. In certain species, embryo formation can then be induced from the protoplast suspension, to the stage of ripening and germination as natural embryos. The culture media will generally contain various amino acids and hormones, necessary for growth and regeneration. Examples of hormones utilized include auxin and cytokinins. It is sometimes advantageous to add glutamic acid and proline to the medium, especially for such species as corn and alfalfa. Efficient regeneration will depend on the medium, on the genotype, and on the history of the culture. If these variables are controlled, regeneration is reproducible. Regeneration also occurs from plant callus, explants, organs or parts. Transformation can be performed in the context of organ or plant part regeneration, (see Methods in Enzymology, Vol. 1 18 and Klee, et al, Annual Review of Plant Physiology, 38:467, 1987). Utilizing the leaf disk-transformation-regeneration method of Horsch, et al, Science, 227:1229. 1985, disks are cultured on selective media, followed by shoot formation in about 2-4 weeks. Shoots that develop are excised from calli and transplanted to appropriate root-inducing selective medium. Rooted plantlets are transplanted to soil as soon as possible after roots appear. The plantlets can be repotted as required, until reaching maturity. In vegetatively propagated crops, the mature transgenic plants are propagated by the taking of cuttings or by tissue culture techniques to produce multiple identical plants. Selection of desirable transgenotes is made and new varieties are obtained and propagated vegetatively for commercial use. In seed propagated crops, the mature transgenic plants can be self crossed to produce a homozygous inbred plant. The inbred plant produces seed containing the newly introduced foreign gene(s). These seeds can be grown to produce plants that would produce the selected phenotype, e.g. early flowering. Parts obtained from the regenerated plant, such as flowers, seeds, leaves, branches, fruit, and the like are included in the invention, provided that these parts comprise cells that have been transformed as described. Progeny and variants, and mutants of the regenerated plants are also included within the scope of the invention, provided that these parts comprise the introduced nucleic acid sequences. The invention includes a plant produced by the method of the invention, including plant tissue, seeds, and other plant cells derived from the genetically modified plant. The above disclosure generally describes the present invention. A more complete understanding can be obtained by reference to the following specific examples which are provided herein for puφoses of illustration only and are not intended to limit the scope of the invention. EXAMPLES Meristems in the aerial portion of a plant have to choose between two alternative fates, shoot or flower meristem, a decision that is regulated by a set of meristem-identity genes (Weigel, D., Annu. Rev. Genetics, 29:19, 1995). Such genes include the snapdragon gene FIMBRIATA (FIM), whose inactivation causes a partial transformation of flowers into shoots (Simon, et al, Cell, 78:99, 1994). The FIM gene has been cloned and shown to be specifically expressed in young flowers (Simon, et al, supra). A gene with significant sequence similarity to FIM has been isolated from Arαbidopsis thαliαnα and shown to correspond to the UFO gene, mutations in which cause phenotypes similar to that of mutations in FIM (Ingraham, et al„ Plant Cell, 7: 1501 , 1995; Levin and Meyerowitz, Plant Cell, 7:529, 1995; Wilkinson an Haughn, Plant Cell, 7: 1485, 1995). The present invention describes isolation of the UFO coding and noncoding nucleic acid sequences. UFO RNA was found to be expressed not only in flowers as previously reported (Ingram, et al, supra), but also in shoot meristems. To test whether the UFO promoter is sufficient to drive expression of a heterologous gene, the promoter was fused to the structural gene β-glucuronidase (GUS). Transgenic Arabidopsis and tobacco plants that carry a fusion of the UFO promoter to a reporter gene encoding β-glucuronidase (GUS) were constructed. These plants express high levels of GUS in shoot meristems, as determined by histochemical staining with the GUS substrate X-gluc (5-bromo-4-chloro-3-indoyl β-D- glucuronide). Functional activity of the UFO promoter in shoot meristems was confirmed by generating transgenic Arabidopsis plants in which the UFO promoter is fused to the nucleic acid sequence encoding the protein of interest encoding the LEAFY (LFY) gene product. High levels of LFY expression are normally restricted to young flowers (Weigel, et al, Cell, 69:843, 1992), and transgenic plants in which LFY is constitutively expressed show transformation of shoots into flowers, apparently due to ecotopic expression of LFY in shoot meristems (Weigel and Nilsson, Nature, 377:495, 1995). A similar phenotype is observed in UFO:. LFY plants, indicating that the UFO promoter can drive functional expression of a heterologous gene in shoot meristems. EXAMPLE 1 ISOLATION AND IDENTIFICATION OF THE UFO GENE The UFO gene was isolated using probes for the snapdragon FIM gene. Genomic DNA was extracted from locally purchased snapdragons, and two adjacent portions of the FIM coding region were amplified by polymerase chain (PCR) reaction (Saiki, et al, Science, 239:487, 1988; Simon, et al, supra). The PCR products were radioactively labeled and used to screen a lambda vector library of Arabidopsis genomic DNA. Duplicate filters were hybridized with the non- overlapping FIM probes, and clones that hybridized to both probes were purified (Sambrook, et al, Molecular Cloning, 2nd Edition, Cold Spring Harbor: Cold Spring Harbor Laboratory, 1989). The FIM cross-hybridizing region was subcloned into plasmid vectors (pBluescript, Stratagene) and the DNA sequence was determined by the Sanger method (Sambrook, et al, supra.) (Figure 1 A). Analysis of the genomic sequence identified an uninterrupted open reading frame of 1326 base pairs, with coding potential for a 442 amino acid long protein that shares significant similarity with the FIM protein (Figure 2). To confirm that this gene corresponded to UFO, a CAPS marker (Konieczny and Ausubel, Plant J., 4:403, 1993) was developed and the map position of the gene determined by mapping it against a previously characterized set of recombinant inbred lines (Lister and Dean, Plant J, 4:745. 1993). The derived map position at 68 cM on chromosome I agrees with the genetic linkage oϊufo mutations to the CAL locus on chromosome I (Levin and Meyerowitz, supra). Genomic DNA was extracted from five ufo mutant alleles, ufo-2 through ufo-6 (Levin and Meyerowitz, supra), and the UFO coding region was amplified by PCR (Saiki, et al, supra). Sequencing revealed single amino acid changes in all five alleles (Figure 2). The four strong alleles ufo-2 through ufo-5 are all associated with nonsense mutations predicted to cause a truncation of the UFO protein. The weak allele ufo-6 has a missense mutation. The map position together with the mutant sequences showed that this clone was derived from the UFO gene. Further confirmation was obtained by complementation of the ufo-2 mutations with a transgene in which the UFO coding region is under the control of the 35S promoter from cauliflower mosaic virus. This promoter is described in Odell, et al, Nature, 313:810, 1985. These results agree with the results reported by Ingraham, et al. , (1995 coding region: GenBank database, accession number X89224). EXAMPLE 2 ANALYSIS OF UFO EXPRESSION AND PROMOTER SEQUENCES Using in situ hybridization to sections oi Arabidopsis plants, the UFO gene was found to be expressed in shoot meristems as well as in young flowers. To study the activity of the UFO promoter, approximately 4 kb of upstream sequences were fused to the GUS reporter (Jefferson, et al, supra). In brief, a BamHI restriction site was introduced downstream of the initiation codon, to produce the sequence ATGGATcC (initiation codon indicated in bold, mutated nucleotide indicated by lower case letter). The 5' fragment used extends from an EcoRI site to this artificial BamHI site (Figure 3). The fragment was cloned as an Hindlll/BamHl fragment upstream of the GUS coding region in the backbone of the pCGNl 547 T-DNA transformation vector (McBride and Summerfelt, Plant Mol. Biol. 14:269, 1990). yielding pDW228, which was transformed into Agrobacterium tumefaciens strain, ASE (Fraley, et al Biotechnology, 2:629, 1985), and introduced in to Arabidopsis thaliana ecotype Columbia plants by the vacuum infiltration method (Bechtold. et al., CR. Acad. Sci., 316: 1 194, 1993). Transgenic plants were selected on kanamycin, seeds were harvested, and progeny were analyzed for GUS activity using the X-gluc substrate at various times during development (Jefferson, et al, E MB OJ., 6:3901 , 1987). Strong expression of GUS was first detected in the apical part of the embryo during early heart stage (Figure 4, panel A). As the shoot apical meristems forms during the toφedo stage, GUS activity becomes restricted to the shoot apical meristem (Figure 4, panel B). In young seedlings that are not florally induced, the same pattern was detected (Figure 4, panel C). Once floral induction has occurred, GUS activity is detected in the shoot apical meristem and in young flowers (Figure 4, panel D). GUS activity is also detected in axillary shoot meristems that form in the axils of rosette leaves. The foregoing is meant to illustrate, but not to limit, the scope of the invention. Indeed, those of ordinary skill in the art can readily envision and produce further embodiments, based on the teachings herein, without undue experimentation. - 1 ! SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: The Salk Institute for Biological Studies (ii) TITLE OF INVENTION: SHOOT MERISTEM SPECIFIC PROMOTER SEQUENCES (iii) NUMBER OF SEQUENCES: 5 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: Fish & Richardson P.C. (B) STREET: 4225 Executive Square, Suite 1400 (C) CITY: La Jolla (D) STATE: CA (E) COUNTRY: USA (F) ZIP: 92037 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentln Release #1.0, Version #1.30 (vii) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: US 08/693,457 (B) FILING DATE: 07-AUG-1996 (C) CLASSIFICATION: (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: Haile, Lisa A. (B) REGISTRATION NUMBER: 38,347 (C) REFERENCE/DOCKET NUMBER: 07251/012001 (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: 619/678-5070 (B) TELEFAX: 619/678-5099 (2) INFORMATION FOR SEQ ID NO : 1 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3139 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 571..1900 (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 1 : TTTATATTTC TGTTAGAAAT AACAACATAT ATCAACTGAT TTTTTACTTC CAATCTCTTT 60 TTGTCAGCAC ACAAATAGAA AAACGTCTGT AAGCTAAGCT ATCAACTAAA ACATTAACAT 120 ATATAATCTT TTACGTTGAT AGAAAATAAA CATAAATTTC TGAGTTATTT TTTTTTTGGT 180 TGGTGTGTCA CTACTTACTT ACTACTATAC CTTTTTAACA ATAAAGAAAC ACTATTTCTT 240 TTTCTATTCA ATATAATATA TGTTTTCTAT TTGTATAAAT CCATTACCTT TGTTTGTTTT 300 ATACCAAATG TTCTTTATAT ATAGTATATG CGACGTTACT CTATTGAAGT CAAGAACATA 360 TCAAAAACCC ATGCAAGAAG CTCACAGAGA AAGACGAAAC GCTTTTGTCT CTTTCTTCAA 420 AACTTTTACA TATGATCTTT GCCTCTTTTC CTACAATGGG TTTTGCATAA CTTTCACCAA 480 AACCCTCCTC AAAAGCCCTT CACATATTCC CAACACAAGA AAATAAACTC TAAATCCACT 540 TTCACCAAAT CTTTTCATTT TTCAGCTAAA ATG GAT TCA ACT GTG TTC ATC AAT 594 Met Asp Ser Thr Val Phe He Asn 1 5 AAC CCA TCT TTA ACC TTA CCT TTC TCT TAC ACA TTT ACC AGT AGC AGC 642 Asn Pro Ser Leu Thr Leu Pro Phe Ser Tyr Thr Phe Thr Ser Ser Ser 10 15 20 AAC AGT AGC ACA ACA ACG AGC ACC ACC ACA GAC TCA AGC TCC GGT CAA 690 Asn Ser Ser Thr Thr Thr Ser Thr Thr Thr Asp Ser Ser Ser Gly Gin 25 30 35 40 TGG ATG GAC GGT CGG ATT TGG AGC AAG CTA CCA CCT CCT CTT CTT GAC 738 Trp Met Asp Gly Arg He Trp Ser Lys Leu Pro Pro Pro Leu Leu Asp 45 50 55 CGC GTC ATT GCT TTT CTT CCA CCT CCG GCG TTT TTC CGG ACA CGT TGC 786 Arg Val He Ala Phe Leu Pro Pro Pro Ala Phe Phe Arg Thr Arg Cys 60 65 70 GTC TGC AAG AGA TTC TAC AGT CTA CTT TTC TCC AAC ACC TTC CTC GAG 834 Val Cys Lys Arg Phe Tyr Ser Leu Leu Phe Ser Asn Thr Phe Leu Glu 75 80 85 ACA TAT CTA CAA CTA CTT CCT CTC CGA CAC AAC TGT TTC CTC TTC TTC 882 Thr Tyr Leu Gin Leu Leu Pro Leu Arg His Asn Cys Phe Leu Phe Phe 90 95 100 AAA CAC AAA ACC CTA AAG AGT TAC ATT TAC AAG AGA GGA GGA ACA AAC 930 Lys His Lys Thr Leu Lys Ser Tyr He Tyr Lys Arg Gly Gly Thr Asn 105 ' 110 115 120 GAT GAT GAT TCC AAT AAA GCT GAA GGC TTT TTG TTT GAT CCT AAT GAG 978 Asp Asp Asp Ser Asn Lys Ala Glu Gly Phe Leu Phe Asp Pro Asn Glu 125 130 135 ATC CGA TGG TAC CGT CTC TCT TTT GCT TAT ATC CCT TCA GGG TTT TAT 1026 He Arg Trp Tyr Arg Leu Ser Phe Ala Tyr He Pro Ser Gly Phe Tyr 140 145 150 CCT TCA GGA TCA TCA GGA GGG TTA GTG AGT TGG GTC TCC GAA GAA GCT 1074 Pro Ser Gly Ser Ser Gly Gly Leu Val Ser Trp Val Ser Glu Glu Ala 155 160 165 GGT CTT AAA ACC ATT CTC TTG TGT AAC CCT CTT GTC GGA TCC GTG AGT 1122 Gly Leu Lys Thr He Leu Leu Cys Asn Pro Leu Val Gly Ser Val Ser 170 175 180 CAG TTG CCA CCA ATA TCA AGG CCA AGG CTT TTC CCT TCG ATA GGT CTC 1170 Gin Leu Pro Pro He Ser Arg Pro Arg Leu Phe Pro Ser He Gly Leu 185 190 195 200 TCG GTA ACA CCA ACC TCT ATT GAT GTT ACT GTC GCT GGA GAT GAT CTC 1218 Ser Val Thr Pro Thr Ser He Asp Val Thr Val Ala Gly Asp Asp Leu 205 210 215 ATA TCT CCT TAC GCT GTG AAA AAC CTC TCA TCG GAG AGT TTC CAT GTC 1266 He Ser Pro Tyr Ala Val Lys Asn Leu Ser Ser Glu Ser Phe His Val 220 225 230 GAC GCC GGC GGA TTC TTT TCC CTC TGG GCG ATG ACT TCT TCT TTG CCA 1314 Asp Ala Gly Gly Phe Phe Ser Leu Trp Ala Met Thr Ser Ser Leu Pro 235 240 245 CGG CTT TGT AGC TTG GAA TCT GGT AAG ATG GTT TAC GTG CAA GGC AAG 1362 Arg Leu Cys Ser Leu Glu Ser Gly Lys Met Val Tyr Val Gin Gly Lys 250 255 260 TTT TAC TGT ATG AAC TAT AGC CCT TTT AGC GTT TTG TCC TAT GAA GTT 1410 Phe Tyr Cys Met Asn Tyr Ser Pro Phe Ser Val Leu Ser Tyr Glu Val 265 270 275 280 ACT GGA AAC CGG TGG ATC AAG ATT CAA GCT CCG ATG AGG AGA TTT CTC 1458 Thr Gly Asn Arg Trp He Lys He Gin Ala Pro Met Arg Arg Phe Leu 285 290 295 AGA TCT CCA AGC TTG TTA GAG AGC AAA GGG AGG CTT ATT CTT GTA GCA 1506 Arg Ser Pro Ser Leu Leu Glu Ser Lys Gly Arg Leu He Leu Val Ala 300 305 310 GCT GTT GAG AAA AGC AAG TTG AAC GTT CCC AAA AGC CTA CGA CTT TGG 1554 Ala Val Glu Lys Ser Lys Leu Asn Val Pro Lys Ser Leu Arg Leu Trp 315 320 325 AGT TTG CAA CAA GAT AAC GCC ACA TGG GTC GAG ATC GAA CGG ATG CCT 1602 Ser Leu Gin Gin Asp Asn Ala Thr Trp Val Glu He Glu Arg Met Pro 330 335 340 CAG CCG CTC TAC ACA CAG TTT GCA GCA GAA GAA GGT GGA AAA GGA TTC 1650 Gin Pro Leu Tyr Thr Gin Phe Ala Ala Glu Glu Gly Gly Lys Gly Phe 345 350 355 360 GAG TGT GTC GGA AAT CAA GAG TTT GTA ATG ATT GTG TTA AGA GGA ACC 1698 Glu Cys Val Gly Asn Gin Glu Phe Val Met He Val Leu Arg Gly Thr 365 370 375 TCG TTG CAG TTG CTG TTT GAT ATA GTG AGA AAA AGC TGG CTG TGG GTC 1746 Ser Leu Gin Leu Leu Phe Asp He Val Arg Lys Ser Trp Leu Trp Val 380 385 390 CCA CCG TGT CCT TAC TCC GGC AGT GGT GGC GGT AGC TCA GGT GGC GGT 1794 Pro Pro Cys Pro Tyr Ser Gly Ser Gly Gly Gly Ser Ser Gly Gly Gly 395 400 405 TCA GAC GGA GAG GTC TTG CAG GGT TTT GCT TAT GAC CCG GTG CTT ACT 1842 Ser Asp Gly Glu Val Leu Gin Gly Phe Ala Tyr Asp Pro Val Leu Thr 410 415 420 ACA CCG GTG GTT AGT CTT CTT GAT CAG TTA ACA CTT CCA TTT CCT GGA 1890 Thr Pro Val Val Ser Leu Leu Asp Gin Leu Thr Leu Pro Phe Pro Gly 425 430 435 440 GTC TGT TAG T TTTTAGACTT TAAGATAAAG AGACTACTTG TGGTTTCCAC 1940 Val Cys * TTCTGACGTT AAGACTGCTT GTTGTTTTCT CAAAATTCTG TTTCTTTTAT CTTATTACTG 2000 TCTGTATGTA GTAAGTTTAT ATTTCTAATG TCAAATGTCT AATCTTTGAC AACATGTCAA 2060 CAACATATAC AGACAGATTT CTAATTGCGT ACAATCCAAT CCAATCCTAA ATCCATCAAA 2120 CTCAAAAACA TAACCCTTGG GAGAATGGTT TCACTTGAGC TTAACCTGGA GAATGAGATG 2180 AACTTTTCTG TTCATTATTC TCCTGAGTTC TTCATTGGCC TCAATTCCTA TCCTCCTGCA 2240 AAATTAGCAT CAACATAAGA TCATCCTTGA GTCATTGATT AGTCAAAAGA ATGAATTATG 2300 ACCGATCTTG TATGCTCTTA CCCGATCTTG CAACCGCCCT TGCCTACAAG AATCTTGCGT 2360 TGGCTAAGTT TAGGAGTGAT GAGATGCTGT TCAATTCTAA GAGACCCGTC ACGCAGCTCT 2420 TTCCAGTCCA CTAGACGGTG CTCCAGACCA TATGGTATTT CCTACAATTT GTTTCAATCA 2480 ATCCTGTAAT TTGTCATCTT GGGATAGACG GAAACTGATA CAAAATGTTA TACTAGTAGA 2540 GGTTGTATTA TTACCTGATG GACATGGTCT AGTAATCTCT CCCTAACAAC TTCAAGAGAA 2600 ATGTTCTTCA AGACTTCTTC ACTCATCGTG AATGCATCTT CTTCCCATGG TTTTTTAACA 2660 GCCTGATCCA TTAAGTATTG GGAAAGATCT TTCACTCCTG ATCCCTTAAG TCCCGATATC 2720 ATGAAGTATC TAGAAAACCA AACAGGGAAA AAGCACATTT CAATCAATTC GAAGACTTCC 2780 CCGGTAATTG TTTTTAAACT GAGTCTGGTA TATATATATC CACCTTTCAT ATGCCGGAAG 2840 ATCTTGGAAC TCCTCAGCAA CCTTTAATAG ATCCTTTTTC TTCTCAACCA GATCAACTTT 2900 GTTCATACAT AAAACGCGCT TTTGTTTCGG ATTTTCTTCT TCTCCCATGT ATTTGATCAA 2960 GCGTACCACT CTTGAATCGG GACTAGATAA ATCAAAGAGA AAACAGAATT CACAAACTAC 3020 AAAATAAGTC TAAGAGAACT CTATTTCTAC TTGTAATTAA TGAAAAACCA CAGTCATGAT 3080 GCCTTCTTCA AAAGAAAGAA ATAGATGTGT CTTCCCATCG GTTTACGGTT CTCAAGCTT 3139 (2) INFORMATION FOR SEQ ID NO : 2 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 443 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 2 : Met Asp Ser Thr Val Phe He Asn Asn Pro Ser Leu Thr Leu Pro Phe 5 10 15 Ser Tyr Thr Phe Thr Ser Ser Ser Asn Ser Ser Thr Thr Thr Ser Thr 20 25 30 Thr Thr Asp Ser Ser Ser Gly Gin Trp Met Asp Gly Arg He Trp Ser 35 40 45 Lys Leu Pro Pro Pro Leu Leu Asp Arg Val He Ala Phe Leu Pro Pro 50 55 60 Pro Ala Phe Phe Arg Thr Arg Cys Val Cys Lys Arg Phe Tyr Ser Leu 65 70 75 80 Leu Phe Ser Asn Thr Phe Leu Glu Thr Tyr Leu Gin Leu Leu Pro Leu 85 90 95 Arg His Asn Cys Phe Leu Phe Phe Lys His Lys Thr Leu Lys Ser Tyr 100 105 110 He Tyr Lys Arg Gly Gly Thr Asn Asp Asp Asp Ser Asn Lys Ala Glu 115 120 125 Gly Phe Leu Phe Asp Pro Asn Glu He Arg Trp Tyr Arg Leu Ser Phe 130 135 140 Ala Tyr He Pro Ser Gly Phe Tyr Pro Ser Gly Ser Ser Gly Gly Leu 145 150 155 160 Val Ser Trp Val Ser Glu Glu Ala Gly Leu Lys Thr He Leu Leu Cys 165 170 175 Asn Pro Leu Val Gly Ser Val Ser Gin Leu Pro Pro He Ser Arg Pro 180 185 190 Arg Leu Phe Pro Ser He Gly Leu Ser Val Thr Pro Thr Ser He Asp 195 200 205 Val Thr Val Ala Gly Asp Asp Leu He Ser Pro Tyr Ala Val Lys Asn 210 215 220 Leu Ser Ser Glu Ser Phe His Val Asp Ala Gly Gly Phe Phe Ser Leu 225 230 235 240 Trp Ala Met Thr Ser Ser Leu Pro Arg Leu Cys Ser Leu Glu Ser Gly 245 250 255 Lys Met Val Tyr Val Gin Gly Lys Phe Tyr Cys Met Asn Tyr Ser Pro 260 265 270 Phe Ser Val Leu Ser Tyr Glu Val Thr Gly Asn Arg Trp He Lys He 275 280 285 Gin Ala Pro Met Arg Arg Phe Leu Arg Ser Pro Ser Leu Leu Glu Ser 290 295 300 Lys Gly Arg Leu He Leu Val Ala Ala Val Glu Lys Ser Lys Leu Asn 305 310 315 320 Val Pro Lys Ser Leu Arg Leu Trp Ser Leu Gin Gin Asp Asn Ala Thr 325 330 335 Trp Val Glu He Glu Arg Met Pro Gin Pro Leu Tyr Thr Gin Phe Ala 340 345 350 Ala Glu Glu Gly Gly Lys Gly Phe Glu Cys Val Gly Asn Gin Glu Phe 355 360 365 Val Met He Val Leu Arg Gly Thr Ser Leu Gin Leu Leu Phe Asp He 370 375 380 Val Arg Lys Ser Trp Leu Trp Val Pro Pro Cys Pro Tyr Ser Gly Ser 385 390 395 400 Gly Gly Gly Ser Ser Gly Gly Gly Ser Asp Gly Glu Val Leu Gin Gly 405 410 415 Phe Ala Tyr Asp Pro Val Leu Thr Thr Pro Val Val Ser Leu Leu Asp 420 425 430 Gin Leu Thr Leu Pro Phe Pro Gly Val Cys * 435 440 (2) INFORMATION FOR SEQ ID NO : 3 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2555 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear ( i) SEQUENCE DESCRIPTION: SEQ ID NO : 3 : CGAATCAGTT AATGTGGGCG ACAAAATAAA ATCAGATTAT GTTTTATTAT TAAGTTTAGA 60 AAGAGATGCT TCATTAAAAG TTTATGCTTT AATGTTAAAT CAGACTATTT ATTATGGGTA 120 CGACTTGTAA GCGTAATTCA AAGTTAAACA AACCTAGTTG GGAAATGGGA AGATAGATGA 180 TTTGATAAAA ACAAGACACT GTTTGGTTTC AGAGACTTCC TTTAGCATCA AAACACAAAC 240 AAAAGCGAAG CCTCTTGAGT TACTGCAAAT AGAGAATATT ATTACCCTTT TGCGACTTGT 300 CAGCTTCAGA TATTCTCACT TGTATTATTA TTTTCACGGT AAACAATGCC TTAAATAAGA 360 AACCCTGATT GGACTTTTGA TCTGACTCTA CTCTTCACTC TTTCTTCTTC TTTATTTTCA 420 GTCATGATGT CTCTCTAACC CTAATCTCAA AAAATCCAAA CTCCTTTTAT TTATTTCTAA 480 ACCTTGATTA TAGCTAGCAA TGATTAATAT AAGAATTTTT TTTCTGGATA AAGAATTAAT 540 TAGAAATTGA GTTGTAAATG TTTTGTGATG TCTAAAATTC TTTTGTTTGC AAATTAGATG 600 TAAATTGATA TATTTGAGAT TTGTATGAAA GCTAGTTTTA TTTTCCCTAA ACAAGAAGTT 660 CATTATCTTG GACTTGGAGG TTTTAGAGTT TGAAAGAGTT TACAATTTAT AAGAAAAAAT 720 AATCACTATA TATATATATA TAGTGTATAT AATGAATTGT TTCACATTAA ATTGCAACAA 780 CATCAAATAA GGGTAACATA CTAACATATA GTTTGTTTGT TTACTCTTTA AAAAAAGGGG 840 ATAAACTAAG AGGCTATTTT CTGCTATAAT TTAGGAACAA ACTGGATCAC ATGACAAAAA 900 TGCATCATAA TTCATATTAA ATTTTGTGTA TATCTATTTC TCATGTTTAG AAATAACATT 960 CTTGTGTGTT ATACATGTTA TCAGTTTTTC TTCCTAGATG GAAGTTTTAT TGTTGGAGTC 1020 TTTTAAAACC ATACTCACTA TGTTCCTCTT TATTTGATGT TTTGGGATTT TAGATAGGAA 1080 ATTAATAAAA AATATGTTTT CTATTTTTAT AAAATTATTT TTTTGTTAGT TTAGTAATTT 1140 TATTTTTCTT TTTTTATTAT TAGTCACAAG CAAAAATAAT AACAATATTT TTATAAAACA 1200 TTAATTTTGG TCGAACAAGT AAAAATAACT CAAAACATCA AATAATTAGA AACTAAAAAA 1260 GTAGATATTG TCAAATTTTG TGTTGAGTTC GAATAAGATA ATGTGGTCTC CTCCAACAAA 1320 ATTATTTAGA ATAAATGCAC TTCTATGACA TTAGAGAACC AACTAATTTA TTTAGAATAA 1380 AACACACATA TATATTAACA TATAAAGTAA TTCTAATTGG CTTGATATAA TATATAAGTA 1440 AAAAAATGAT CTTAATAATC TCTAGTTTTC TTGGGTTGAT CTCCACGAGT ACAATTTGAC 1500 TGACCATTAT AGAAGTTGAG AAGCGTGCAT GTAATAAAAG TTGTATATTA CAAATTAGAG 1560 AGGAAAAAGA AAGAAAGAAA AAAGATTTGA AGATGTGATC AAGTGTGAAA AGTATTGGAG 1620 TAGTCTCCAA ATTAATAATT TCGATGCTGG GCATTGACAA GATAACTCTG AAGCTCTCAA 1680 CTTTAAGACC ATCACTTCCT CTCCACCATT TTCACGTTTA CCCAAACACA CACATATACA 1740 AACAAAATTT TGTTAGTCAA TAATTATCAC CAAACTGGGG TTATAACAAG GCTTTTGGAT 1800 ACTTGTGCTT GTTGATGTTC TAGGTTCGTA TGATAACAAA GTACATCCGT TATATATATT 1860 CGAAACACAC TTTAATATTA AAAATATATA TCCAATTTTC TTGTGAAATT TAGATTATTT 1920 GGAATTAAAC CTATTTCTCT TGTCTTGGCC ACTTGACCGG TTTAGTTTTT TAGACGTATT 1980 TTATTATTTC TGTTTAGAAA ATAACAACAT ATATCAACTG ATTTTTTACT TCCAATCTCT 2040 TTTTGTCAGC ACACAAATAG AAAAACGTCT GTAAGCTAAG CTATCAACTA AAACATTAAC 2100 ATATATAATC TTTTACGTTG ATAGAAAATA AACATAAATT TCTGAGTTAT TTTTTTTTTG 2160 GTTGGTGTGT CACTACTTAC TTACTACTAT ACCTTTTTAA CAATAAAGAA ACACTATTTC 2220 TTTTTCTATT CAATATAATA TATGTTTTCT ATTTGTA AA ATCCATTACC TTTGTTTGTT 2280 TTATACCAAA TGTTCTTTAT ATATAGTATA TGCGACGTTA CTCTATTGAA GTCAAGAACA 2340 TATCAAAAAC CCATGCAAGA AGCTCACAGA GAAAGACGAA ACGCTTTTGT CTCTTTCTTC 2400 AAAACTTTTA CATATGATCT TTGCCTCTTT TCCTACAATG GGTTTTGCAT AACTTTCACC 2460 AAAACCCTCC TCAAAAGCCC TTCACATATT CCCAACACAA GAAAATAAAC TCTAAATCCA 2520 CTTTCACCAA ATCTTTTCAT TTTTCAGCTA AAATG 2555 (2) INFORMATION FOR SEQ ID NO : 4 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 442 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 4 : Met Asp Ser Thr Val Phe He Asn Asn Pro Ser Leu Thr Leu Pro Phe 1 5 10 15 Ser Tyr Thr Phe Thr Ser Ser Ser Asn Ser Ser Thr Thr Thr Ser Thr 20 25 30 Thr Thr Asp Ser Ser Ser Gly Gin Trp Met Asp Gly Arg He Trp Ser 35 40 45 Lys Leu Pro Pro Pro Leu Leu Asp Arg Val He Ala Phe Leu Pro Pro 50 55 60 Pro Ala Phe Phe Arg Thr Arg Cys Val Cys Lys Arg Phe Tyr Ser Leu 65 70 75 80 Leu Phe Ser Asn Thr Phe Leu Glu Thr Tyr Leu Gin Leu Leu Pro Leu 85 90 95 Arg His Asn Cys Phe Leu Phe Phe Lys His Lys Thr Leu Lys Ser Tyr 100 105 110 He Tyr Lys Arg Gly Gly Thr Asn Asp Asp Asp Ser Asn Lys Ala Glu 115 120 125 Gly Phe Leu Phe Asp Pro Asn Glu He Arg Trp Tyr Arg Leu Ser Phe 130 135 1 0 Ala Tyr He Pro Ser Gly Phe Tyr Pro Ser Gly Ser Ser Gly Gly Leu 145 150 155 160 Val Ser Trp Val Ser Glu Glu Ala Gly Leu Lys Thr He Leu Leu Cys 165 170 175 Asn Pro Leu Val Gly Ser Val Ser Gin Leu Pro Pro He Ser Arg Pro 180 185 190 Arg Leu Phe Pro Ser He Gly Leu Ser Val Thr Pro Thr Ser He Asp 195 200 205 Val Thr Val Ala Gly Asp Asp Leu He Ser Pro Tyr Ala Val Lys Asn 210 215 220 Leu Ser Ser Glu Ser Phe His Val Asp Ala Gly Gly Phe Phe Ser Leu 225 230 235 240 Trp Ala Met Thr Ser Ser Leu Pro Arg Leu Cys Ser Leu Glu Ser Gly 245 250 255 Lys Met Val Tyr Val Gin Gly Lys Phe Tyr Cys Met Asn Tyr Ser Pro 260 265 270 Phe Ser Val Leu Ser Tyr Glu Val Thr Gly Asn Arg Trp He Lys He 275 280 285 Gin Ala Pro Met Arg Arg Phe Leu Arg Ser Pro Ser Leu Leu Glu Ser 290 295 300 Lys Gly Arg Leu He Leu Val Ala Ala Val Glu Lys Ser Lys Leu Asn 305 310 315 320 Val Pro Lys Ser Leu Arg Leu Trp Ser Leu Gin Gin Asp Asn Ala Thr 325 330 335 Trp Val Glu He Glu Arg Met Pro Gin Pro Leu Tyr Thr Gin Phe Ala 340 345 350 Ala Glu Glu Gly Gly Lys Gly Phe Glu Cys Val Gly Asn Gin Glu Phe 355 360 365 Val Met He Val Leu Arg Gly Thr Ser Leu Gin Leu Leu Phe Asp He 370 375 380 Val Arg Lys Ser Trp Leu Trp Val Pro Pro Cys Pro Tyr Ser Gly Ser 385 390 395 400 Gly Gly Gly Ser Ser Gly Gly Gly Ser Asp Gly Glu Val Leu Gin Gly 405 410 415 Phe Ala Tyr Asp Pro Val Leu Thr Thr Pro Val Val Ser Leu Leu Asp 420 425 430 Gin Leu Thr Leu Pro Phe Pro Gly Val Cys 435 440 (2) INFORMATION FOR SEQ ID NO : 5 : (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 164 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 5 : Glu Ala Phe Gin Thr He Phe Asn Leu Pro Gly Thr Thr Pro Thr He 1 5 10 15 Asn Leu Gin Asn Met He Met Thr Thr Asn Cys Arg Gin Lys He He 20 25 30 Cys Ser Ser Trp He Thr Leu His Ala Ser He Trp Met Gin Gin Ser 35 40 45 He His His Asn Asn Asn Ser Ala Arg Pro Thr Tyr Tyr Gin Thr Leu 50 55 60 Lys He Pro Leu Pro Ser Ala Ser Leu He Cys Asp Ser Pro Asn Ser 65 70 75 80 Thr Asn Thr Ala He Ser Thr Leu Glu Cys Thr Thr He Asn Ser He 85 90 95 Ser Phe Thr He Val Tyr He Asn Thr Arg His Arg Asp He Ser Leu 100 105 110 Gin Cys Thr Val Lys Ala Glu Cys Gly Thr He Gin He Glu He Arg 115 120 125 Ser Ala His Ala Val Leu He Ser Tyr Asp Lys Ala Val Met Phe Cys 130 135 140 Gin Val Val Asp Asp Glu His Glu Arg Ala Val He Thr Pro Glu Gin 145 150 155 160 Ser Phe Thr Ala

Claims: What is claimed is: 1. A nucleic acid construct comprising a non-coding regulatory sequence isolated upstream from a plant Unusual Floral Organs (UFO) gene, wherein said non-coding regulatory sequence is operably associated with a nucleic acid sequence which expresses a product selected from a protein of interest or antisense RNA, and wherein said nucleic acid sequence is heterologous to said non-coding sequence. 2. The nucleic acid construct of claim 1 wherein said non-coding sequence is derived from the nucleotide sequence shown in Figure IB. 3. The nucleic acid construct of claim 1 , wherein said non-coding sequence comprises a transcriptional and translational initiation region. 4. The nucleic acid construct of claim 3, further comprising a transcriptional termination region functional in a plant cell. 5. The nucleic acid construct of claim 1, wherein said nucleic acid sequence encodes a Bacillus thuringiensis toxin. 6. A transgenic plant cell comprising a nucleic acid construct according to claim 1. 7. The transgenic plant cell of claim 6, further comprising a selectable marker. 8. A plant comprising a transgenic plant cell according to claim 6. 9. An isolated nucleic acid comprising a non-coding regulatory sequence isolated upstream from a plant Unusual Floral Organs (UFO) gene. 10. A method of providing increased transcription of a nucleic acid sequence in shoot meristem tissue of a plant, said method comprising: subjecting a genetically engineered plant to conditions suitable for growth wherein said plant has integrated in its genome a nucleic acid construct comprising a non-coding regulatory sequence isolated upstream from an Unusual Floral Organs (UFO) gene, wherein said non-coding regulatory sequence is operably associated with a nucleic acid sequence expressing a product selected from proteins of interest or antisense RNA and wherein said nucleic acid sequence is heterologous to said non- coding sequence, whereby transcription of said nucleic acid sequence is increased in said meristem tissue. 1 1. The method of claim 10, wherein said non-coding region comprises a transcriptional and translational initiation region. 12. The method of claim 10, wherein the nucleic acid sequence encodes Bacillus thuringiensis toxin. 13. A nucleic acid sequence derived from the nucleic acid sequence of Figure IB.

Inventors: LEE ILHA, WEIGEL DETLEF, LEE, ILHA, WEIGEL, DETLEF
Applicants: SALK INST FOR BIOLOGICAL STUDI, THE SALK INSTITUTE FOR BIOLOGICAL STUDIES
Application year: 1997
Main classification: A01H5
IPC codes: A01H5, C07K14, C12N5, C12N15, C12R1